{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:eflimrufusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:izenivetmab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:milpocitide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03769506: Phase 3 Interventional Active, not recruiting Head and Neck Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Class:
PROTEIN